tPA Helpers in the Treatment of Acute Ischemic Stroke: Are They Ready for Clinical Use?
Tissue plasminogen activator (tPA) is the only therapeutic agent approved to treat patients with acute ischemic stroke. The clinical benefits of tPA manifest when the agent is administered within 4.5 hours of stroke onset. However, tPA administration, especially delayed administration, is associated...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Stroke Society
2019-05-01
|
| Series: | Journal of Stroke |
| Subjects: | |
| Online Access: | http://www.j-stroke.org/upload/pdf/jos-2019-00584.pdf |